Manufacturer Supply High Purity CAS 474-25-9 Cdca Chenodeoxycholic Acid

• Certification: ISO, FDA, HACCP
• Storage Method: Normal
• Extraction Process: Physical
• Application: Cosmetics, Health Care Products, Medicine
• State: Powder
• Extract Source: Goose
• Model NO.: TY-02AL
• CAS No.: 474-25-9
• Appearance: White Powder
• Einecs: 616-396-9
• Assay: 99%
• Shelf: 2 Years
• Transport Package: 25kg/Drum 1kg, 10kg, 100kg, 200kg
• Specification: 25kg/drum
• Trademark: tongyon
• Origin: China
• Production Capacity: 5000kg/Month

Product Description

 

Product name	Chenodeoxycholic acid
CAS	474-25-9
Appearance	51186-83-5
Assay	99%
Storage	Cool and Protect from light

Product Name:Chenodeoxycholic acid
CAS:474-25-9
MF:C24H40O4
MW:392.57
EINECS:207-481-8
Mol File:474-25-9.mol  
Melting point:165-167 °C(lit.)
alpha 12 º (c=1, CHCl3)
Boiling point:437.26°C (rough estimate)
Density 0.9985 (rough estimate)
refractive index 1.4460 (estimate)
Flash point:9ºC
storage temp. Refrigerator
solubility PRACTICALLY INSOLUBLE
form Powder
pkapKa 4.34 (Uncertain)
color White to off-white
Water Solubility PRACTICALLY INSOLUBLE







UsesChenodeoxycholic acid is a bile acid synthesized in the liver from cholesterol. henodeoxycholic acid has been used in a study to assess its effects as a long-term replacement therapy for cerebrotendinous xanthomatosis (CTX). It has also been used in a study to investigate its effects on the small-intestinal absorption of bile acids in patients with ileostomies.
DescriptionChenodeoxycholic acid is the first agent to be introduced into the US market for the treatment of radiolucent gallstones. Large scale clinical trials have demonstrated the safety and efficacy of this agent. Chenodeoxycholic acid reduces the biliary concentration of cholesterol relative to that of bile acids and phospholipid, reducing the saturation and thus the lithogenicity of the bile. Success rates in dissolving gallstones are in the range of 50-70% within 4-24 months of treatment. Continuation of the drug after stone dissolution may be required to prevent reoccurrence. Chenodeoxycholic acid is the 7α-isomer of ursodeoxycholic acid which was introduced into the European market in 1978.

The urolithin precursors, ellagic acid and ellagitannins, naturally occur in some food sources such as pomegranates, guavas, tea, pecans, nuts, and berries such as strawberries, black raspberries and blackberries.  Urolithins are found in the plasma as glucuronide and sulfate conjugates at low concentrations    Urolithin A (UA) is the most prevalent metabolite of ellagitannins. However, urolithin A is not known to occur naturally in any dietary sources.

Urolithin B (UB) is an abundant metabolite produced in the gut through transformation of ellagitannins. Urolithin B is the last product after all the other urolithin derivatives are catabolized. Urolithin B is found in urine as urolithin B glucuronide.

GuangZhou TongYi biochemistry technology Co., Ltd is a company specializing in active pharmaceutical ingredient
(API), biology, plant extracts, chemical raw materials, fine chemicals, pharmaceutical intermediates, cosmetics raw
material. Our company has always adhered to the company philosophy of integrity, professionalism, quality first, and
customer service. With the efforts of all the company's employees, it has established long-term
and stable cooperative relations with many domestic and foreign customers, and won the unanimous trust of domestic
and foreign customers. With good comments, our company have made great progress.

Our company takes pioneering and innovative, high-quality and efficient as the code of conduct, and strives to provide
customers with efficient services,
high-quality products, and reasonable prices. We have established a customer demand-oriented, flexible, diverse and customizable service according to the different needs of different customers. Mode, and ultimately achieve the goal of
win-win.

Our company focuses on the future and the world, and will continue to devote itself to technological progress and the
development of new products in the future, hoping to work hand in hand with new and old friends at home and abroad
to create a better future.